{"id":415,"date":"2026-06-10T17:29:21","date_gmt":"2026-06-10T15:29:21","guid":{"rendered":"https:\/\/www.fprh.fr\/?p=415"},"modified":"2026-06-10T17:29:21","modified_gmt":"2026-06-10T15:29:21","slug":"remboursement-du-glp1-wegowy","status":"publish","type":"post","link":"https:\/\/www.fprh.fr\/index.php\/2026\/06\/10\/remboursement-du-glp1-wegowy\/","title":{"rendered":"Remboursement du GLP1 WEGOWY"},"content":{"rendered":"\n
Suite \u00e0 l\u2019Arr\u00eat\u00e9 du 23 mai 2026 modifiant la liste des sp\u00e9cialit\u00e9s pharmaceutiques remboursables aux assur\u00e9s sociaux <\/td><\/tr>
A partir du 15 juin 2026<\/strong>, la sp\u00e9cialit\u00e9 WEGOVY\u00ae<\/strong> sera prise en charge par la S\u00e9curit\u00e9 Sociale selon les conditions pr\u00e9sent\u00e9es ci-dessous.<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n
\n

https:\/\/www.legifrance.gouv.fr\/jorf\/id\/JORFTEXT000054144081<\/a>
Chez l\u2019adulte en cas d\u2019\u00e9chec de la prise en charge nutritionnelle bien conduite (< 5 % de perte de poids \u00e0 six mois), en compl\u00e9ment d\u2019un r\u00e9gime hypocalorique et d\u2019une augmentation de l\u2019activit\u00e9 physique pour la gestion du poids, incluant la perte de poids et le maintien du poids :
\u2013 patients ayant un indice de masse corporelle (IMC) initial \u2265 40 kg\/m2 sans comorbidit\u00e9 ;
\u2013 patients ayant un indice de masse corporelle (IMC) initial \u2265 35 kg\/m2 avec une comorbidit\u00e9 :
\u2013 un diab\u00e8te de type 2 ;
\u2013 une HTA n\u00e9cessitant un traitement m\u00e9dicamenteux
\u2013 une hypertriglyc\u00e9rid\u00e9mie > 5 g\/L (contr\u00f4l\u00e9e \u00e0 plusieurs reprises, en dehors de toute consommation d\u2019alcool et en dehors du d\u00e9s\u00e9quilibre d\u2019un diab\u00e8te de type 2) et r\u00e9sistante au traitement habituel comprenant les mesures nutritionnelles ;
\u2013 une st\u00e9atoh\u00e9patite non alcoolique (NASH) ou une fibrose h\u00e9patique (quel que soit le stade de la fibrose). La st\u00e9atose isol\u00e9e n\u2019est pas une comorbidit\u00e9 retenue pour l\u2019indication de chirurgie bariatrique ;
\u2013 un syndrome des ovaires polykystiques chez la patiente en \u00e2ge de procr\u00e9er ;
\u2013 un probl\u00e8me de fertilit\u00e9 masculine ou f\u00e9minine avec un projet d\u2019AMP, sur proposition de l\u2019\u00e9quipe d\u2019AMP ;
\u2013 une maladie r\u00e9nale chronique (jusqu\u2019au stade d\u2019IRC mod\u00e9r\u00e9e : stade 3A ou 3B) apr\u00e8s avis du n\u00e9phrologue, voire une insuffisance r\u00e9nale s\u00e9v\u00e8re ou terminale avec un projet de transplantation r\u00e9nale. Dans ce dernier cas, la d\u00e9cision doit \u00eatre discut\u00e9e au cas par cas de fa\u00e7on coll\u00e9giale avec l\u2019\u00e9quipe de transplantation et r\u00e9alis\u00e9e dans des centres disposant d\u2019une structure de dialyse ;
\u2013 une cirrhose Child A, apr\u00e8s accord avec l\u2019h\u00e9patologue ;
\u2013 un syndrome d\u2019apn\u00e9es-hypopn\u00e9es obstructives du sommeil (SAHOS) avec un IAH \u2265 15\/h ;
\u2013 un asthme s\u00e9v\u00e8re en lien avec l\u2019ob\u00e9sit\u00e9 apr\u00e8s avis d\u2019un pneumologue, d\u2019un ORL et\/ou d\u2019un allergologue ;
\u2013 des lombalgies chroniques, une coxarthrose, une gonarthrose, invalidantes, document\u00e9es, apr\u00e8s avis
rhumatologique et\/ou orthop\u00e9dique confirmant les b\u00e9n\u00e9fices attendus par la perte de poids ;
\u2013 une incontinence urinaire invalidante ne r\u00e9pondant pas aux modifications th\u00e9rapeutiques du mode de vie associ\u00e9es aux traitements m\u00e9dicamenteux de l\u2019incontinence urinaire et, si besoin, de la constipation, apr\u00e8s confirmation par un gyn\u00e9cologue ou un urologue que la perte de poids post-chirurgie bariatrique est susceptible d\u2019am\u00e9liorer les troubles urinaires ;
\u2013 une hernie pari\u00e9tale ou une \u00e9ventration symptomatique ou complexe dont le traitement chirurgical impose une perte de poids avant la chirurgie pari\u00e9tale ;
\u2013 une hypertension intracr\u00e2nienne idiopathique r\u00e9sistant \u00e0 une prise en charge neurologique bien conduite ;
\u2013 la pr\u00e9sence d\u2019un handicap moteur avec ou sans parapl\u00e9gie. Il est recommand\u00e9 de r\u00e9aliser ces chirurgies au cas par cas apr\u00e8s avis d\u2019un m\u00e9decin de m\u00e9decine physique et de r\u00e9adaptation (MPR) ou d\u2019un neurologue.

L\u2019indication op\u00e9ratoire devra \u00eatre valid\u00e9e en RCP de recours dans un centre de niveau 3 pour la prise en charge de l\u2019ob\u00e9sit\u00e9.

Au regard des sp\u00e9cificit\u00e9s du produit et afin de garantir un bon usage de WEGOVY\u00ae (injection sous-cutan\u00e9e, position dans la strat\u00e9gie th\u00e9rapeutique en seconde intention en association \u00e0 des mesures hygi\u00e9no-di\u00e9t\u00e9tiques, incertitudes d\u2019un effet rebond \u00e0 l\u2019arr\u00eat du traitement), la prescription initiale du m\u00e9dicament est r\u00e9serv\u00e9e aux professionnels exer\u00e7ant dans les structures de sant\u00e9 impliqu\u00e9es dans la prise en charge de l\u2019ob\u00e9sit\u00e9 de niveaux de recours 2 et 3, \u00e0 savoir : les m\u00e9decins exer\u00e7ant en CSO, dans un CHU, dans un SMR de \u00ab gastro-ent\u00e9rologie, endocrinologie, diab\u00e9tologie, nutrition \u00bb ou les endocrinologues en lien avec un CSO.<\/strong><\/p>\n<\/blockquote>\n","protected":false},"excerpt":{"rendered":"

Suite \u00e0 l\u2019Arr\u00eat\u00e9 du 23 mai 2026 modifiant la liste des sp\u00e9cialit\u00e9s pharmaceutiques remboursables aux assur\u00e9s sociaux A partir du 15 juin 2026, la sp\u00e9cialit\u00e9 WEGOVY\u00ae sera prise en charge par la S\u00e9curit\u00e9 Sociale selon les conditions pr\u00e9sent\u00e9es ci-dessous. https:\/\/www.legifrance.gouv.fr\/jorf\/id\/JORFTEXT000054144081 Chez l\u2019adulte en cas d\u2019\u00e9chec de la prise en charge nutritionnelle bien conduite (< 5 […]\n<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[14,10],"tags":[17,18,21,20,26],"class_list":["post-415","post","type-post","status-publish","format-standard","hentry","category-actualite","category-masld-mash","tag-cancer","tag-foie","tag-mash","tag-masld","tag-traitement"],"yoast_head":"\nRemboursement du GLP1 WEGOWY - FPRH - la federation des centres experts h\u00e9patites<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.fprh.fr\/index.php\/2026\/06\/10\/remboursement-du-glp1-wegowy\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Remboursement du GLP1 WEGOWY - FPRH - la federation des centres experts h\u00e9patites\" \/>\n<meta property=\"og:description\" content=\"Suite \u00e0 l\u2019Arr\u00eat\u00e9 du 23 mai 2026 modifiant la liste des sp\u00e9cialit\u00e9s pharmaceutiques remboursables aux assur\u00e9s sociaux A partir du 15 juin 2026, la sp\u00e9cialit\u00e9 WEGOVY\u00ae sera prise en charge par la S\u00e9curit\u00e9 Sociale selon les conditions pr\u00e9sent\u00e9es ci-dessous. https:\/\/www.legifrance.gouv.fr\/jorf\/id\/JORFTEXT000054144081 Chez l\u2019adulte en cas d\u2019\u00e9chec de la prise en charge nutritionnelle bien conduite (< 5 […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.fprh.fr\/index.php\/2026\/06\/10\/remboursement-du-glp1-wegowy\/\" \/>\n<meta property=\"og:site_name\" content=\"FPRH - la federation des centres experts h\u00e9patites\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-10T15:29:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.fprh.fr\/wp-content\/uploads\/2025\/05\/logo_FPRH_2025.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"341\" \/>\n\t<meta property=\"og:image:height\" content=\"172\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin9197\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin9197\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.fprh.fr\/index.php\/2026\/06\/10\/remboursement-du-glp1-wegowy\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.fprh.fr\/index.php\/2026\/06\/10\/remboursement-du-glp1-wegowy\/\"},\"author\":{\"name\":\"admin9197\",\"@id\":\"https:\/\/www.fprh.fr\/#\/schema\/person\/126da9c3dcc97fee69a4a1d857c202f4\"},\"headline\":\"Remboursement du GLP1 WEGOWY\",\"datePublished\":\"2026-06-10T15:29:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.fprh.fr\/index.php\/2026\/06\/10\/remboursement-du-glp1-wegowy\/\"},\"wordCount\":693,\"publisher\":{\"@id\":\"https:\/\/www.fprh.fr\/#organization\"},\"keywords\":[\"cancer\",\"foie\",\"MASH\",\"MASLD\",\"Traitement\"],\"articleSection\":[\"Actualit\u00e9\",\"MASLD\/MASH\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.fprh.fr\/index.php\/2026\/06\/10\/remboursement-du-glp1-wegowy\/\",\"url\":\"https:\/\/www.fprh.fr\/index.php\/2026\/06\/10\/remboursement-du-glp1-wegowy\/\",\"name\":\"Remboursement du GLP1 WEGOWY - FPRH - la federation des centres experts h\u00e9patites\",\"isPartOf\":{\"@id\":\"https:\/\/www.fprh.fr\/#website\"},\"datePublished\":\"2026-06-10T15:29:21+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.fprh.fr\/index.php\/2026\/06\/10\/remboursement-du-glp1-wegowy\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.fprh.fr\/index.php\/2026\/06\/10\/remboursement-du-glp1-wegowy\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.fprh.fr\/index.php\/2026\/06\/10\/remboursement-du-glp1-wegowy\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.fprh.fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Remboursement du GLP1 WEGOWY\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.fprh.fr\/#website\",\"url\":\"https:\/\/www.fprh.fr\/\",\"name\":\"FPRH - la federation des centre experts h\u00e9patites\",\"description\":\"Ensemble contre les Maladies du Foie !\",\"publisher\":{\"@id\":\"https:\/\/www.fprh.fr\/#organization\"},\"alternateName\":\"FPRH\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.fprh.fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.fprh.fr\/#organization\",\"name\":\"F\u00e9d\u00e9ration nationale des P\u00f4les de r\u00e9f\u00e9rence et R\u00e9seaux H\u00e9patites (FPRH)\",\"url\":\"https:\/\/www.fprh.fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.fprh.fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.fprh.fr\/wp-content\/uploads\/2025\/05\/logo_FPRH_2025.jpg\",\"contentUrl\":\"https:\/\/www.fprh.fr\/wp-content\/uploads\/2025\/05\/logo_FPRH_2025.jpg\",\"width\":341,\"height\":172,\"caption\":\"F\u00e9d\u00e9ration nationale des P\u00f4les de r\u00e9f\u00e9rence et R\u00e9seaux H\u00e9patites (FPRH)\"},\"image\":{\"@id\":\"https:\/\/www.fprh.fr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.linkedin.com\/company\/fprh-f\u00e9d\u00e9ration-nationale-des-p\u00f4les-de-r\u00e9f\u00e9rence-et-r\u00e9seaux-h\u00e9patites\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.fprh.fr\/#\/schema\/person\/126da9c3dcc97fee69a4a1d857c202f4\",\"name\":\"admin9197\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.fprh.fr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1bbabf651aecd56a914482a24796c33c72e51240bce2f163e4aa184744001d45?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1bbabf651aecd56a914482a24796c33c72e51240bce2f163e4aa184744001d45?s=96&d=mm&r=g\",\"caption\":\"admin9197\"},\"sameAs\":[\"http:\/\/byfvotf.cluster100.hosting.ovh.net\"],\"url\":\"https:\/\/www.fprh.fr\/index.php\/author\/admin9197\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Remboursement du GLP1 WEGOWY - FPRH - la federation des centres experts h\u00e9patites","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.fprh.fr\/index.php\/2026\/06\/10\/remboursement-du-glp1-wegowy\/","og_locale":"fr_FR","og_type":"article","og_title":"Remboursement du GLP1 WEGOWY - FPRH - la federation des centres experts h\u00e9patites","og_description":"Suite \u00e0 l\u2019Arr\u00eat\u00e9 du 23 mai 2026 modifiant la liste des sp\u00e9cialit\u00e9s pharmaceutiques remboursables aux assur\u00e9s sociaux A partir du 15 juin 2026, la sp\u00e9cialit\u00e9 WEGOVY\u00ae sera prise en charge par la S\u00e9curit\u00e9 Sociale selon les conditions pr\u00e9sent\u00e9es ci-dessous. https:\/\/www.legifrance.gouv.fr\/jorf\/id\/JORFTEXT000054144081 Chez l\u2019adulte en cas d\u2019\u00e9chec de la prise en charge nutritionnelle bien conduite (< 5 […]","og_url":"https:\/\/www.fprh.fr\/index.php\/2026\/06\/10\/remboursement-du-glp1-wegowy\/","og_site_name":"FPRH - la federation des centres experts h\u00e9patites","article_published_time":"2026-06-10T15:29:21+00:00","og_image":[{"width":341,"height":172,"url":"https:\/\/www.fprh.fr\/wp-content\/uploads\/2025\/05\/logo_FPRH_2025.jpg","type":"image\/jpeg"}],"author":"admin9197","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"admin9197","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.fprh.fr\/index.php\/2026\/06\/10\/remboursement-du-glp1-wegowy\/#article","isPartOf":{"@id":"https:\/\/www.fprh.fr\/index.php\/2026\/06\/10\/remboursement-du-glp1-wegowy\/"},"author":{"name":"admin9197","@id":"https:\/\/www.fprh.fr\/#\/schema\/person\/126da9c3dcc97fee69a4a1d857c202f4"},"headline":"Remboursement du GLP1 WEGOWY","datePublished":"2026-06-10T15:29:21+00:00","mainEntityOfPage":{"@id":"https:\/\/www.fprh.fr\/index.php\/2026\/06\/10\/remboursement-du-glp1-wegowy\/"},"wordCount":693,"publisher":{"@id":"https:\/\/www.fprh.fr\/#organization"},"keywords":["cancer","foie","MASH","MASLD","Traitement"],"articleSection":["Actualit\u00e9","MASLD\/MASH"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.fprh.fr\/index.php\/2026\/06\/10\/remboursement-du-glp1-wegowy\/","url":"https:\/\/www.fprh.fr\/index.php\/2026\/06\/10\/remboursement-du-glp1-wegowy\/","name":"Remboursement du GLP1 WEGOWY - FPRH - la federation des centres experts h\u00e9patites","isPartOf":{"@id":"https:\/\/www.fprh.fr\/#website"},"datePublished":"2026-06-10T15:29:21+00:00","breadcrumb":{"@id":"https:\/\/www.fprh.fr\/index.php\/2026\/06\/10\/remboursement-du-glp1-wegowy\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.fprh.fr\/index.php\/2026\/06\/10\/remboursement-du-glp1-wegowy\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.fprh.fr\/index.php\/2026\/06\/10\/remboursement-du-glp1-wegowy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.fprh.fr\/"},{"@type":"ListItem","position":2,"name":"Remboursement du GLP1 WEGOWY"}]},{"@type":"WebSite","@id":"https:\/\/www.fprh.fr\/#website","url":"https:\/\/www.fprh.fr\/","name":"FPRH - la federation des centre experts h\u00e9patites","description":"Ensemble contre les Maladies du Foie !","publisher":{"@id":"https:\/\/www.fprh.fr\/#organization"},"alternateName":"FPRH","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.fprh.fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.fprh.fr\/#organization","name":"F\u00e9d\u00e9ration nationale des P\u00f4les de r\u00e9f\u00e9rence et R\u00e9seaux H\u00e9patites (FPRH)","url":"https:\/\/www.fprh.fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.fprh.fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.fprh.fr\/wp-content\/uploads\/2025\/05\/logo_FPRH_2025.jpg","contentUrl":"https:\/\/www.fprh.fr\/wp-content\/uploads\/2025\/05\/logo_FPRH_2025.jpg","width":341,"height":172,"caption":"F\u00e9d\u00e9ration nationale des P\u00f4les de r\u00e9f\u00e9rence et R\u00e9seaux H\u00e9patites (FPRH)"},"image":{"@id":"https:\/\/www.fprh.fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/fprh-f\u00e9d\u00e9ration-nationale-des-p\u00f4les-de-r\u00e9f\u00e9rence-et-r\u00e9seaux-h\u00e9patites\/"]},{"@type":"Person","@id":"https:\/\/www.fprh.fr\/#\/schema\/person\/126da9c3dcc97fee69a4a1d857c202f4","name":"admin9197","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.fprh.fr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1bbabf651aecd56a914482a24796c33c72e51240bce2f163e4aa184744001d45?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1bbabf651aecd56a914482a24796c33c72e51240bce2f163e4aa184744001d45?s=96&d=mm&r=g","caption":"admin9197"},"sameAs":["http:\/\/byfvotf.cluster100.hosting.ovh.net"],"url":"https:\/\/www.fprh.fr\/index.php\/author\/admin9197\/"}]}},"_links":{"self":[{"href":"https:\/\/www.fprh.fr\/index.php\/wp-json\/wp\/v2\/posts\/415","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fprh.fr\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fprh.fr\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fprh.fr\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fprh.fr\/index.php\/wp-json\/wp\/v2\/comments?post=415"}],"version-history":[{"count":1,"href":"https:\/\/www.fprh.fr\/index.php\/wp-json\/wp\/v2\/posts\/415\/revisions"}],"predecessor-version":[{"id":416,"href":"https:\/\/www.fprh.fr\/index.php\/wp-json\/wp\/v2\/posts\/415\/revisions\/416"}],"wp:attachment":[{"href":"https:\/\/www.fprh.fr\/index.php\/wp-json\/wp\/v2\/media?parent=415"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fprh.fr\/index.php\/wp-json\/wp\/v2\/categories?post=415"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fprh.fr\/index.php\/wp-json\/wp\/v2\/tags?post=415"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}